155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

S. K. Do; S. Y. Lee; J. E. Choi; M. J. Hong; J. H. Lee; J. Y. Park

doi:10.1016/S1556-0864(16)30265-9

155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

S. K. Do, S. Y. Lee, J. E. Choi, M. J. Hong, J. H. Lee, J. Y. Park

Department of Medicine

Kyungpook National University

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	S125
Journal	Journal of Thoracic Oncology
Volume	11
Issue number	4
DOIs	https://doi.org/10.1016/S1556-0864(16)30265-9
State	Published - Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1556-0864(16)30265-9

Cite this

@article{cb0645e4babc48b28efc8533d388b5d9,

title = "155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy",

author = "Do, {S. K.} and Lee, {S. Y.} and Choi, {J. E.} and Hong, {M. J.} and Lee, {J. H.} and Park, {J. Y.}",

year = "2016",

month = apr,

doi = "10.1016/S1556-0864(16)30265-9",

language = "English",

volume = "11",

pages = "S125",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - 155P

T2 - PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

AU - Do, S. K.

AU - Lee, S. Y.

AU - Choi, J. E.

AU - Hong, M. J.

AU - Lee, J. H.

AU - Park, J. Y.

PY - 2016/4

Y1 - 2016/4

UR - http://www.scopus.com/inward/record.url?scp=85029246459&partnerID=8YFLogxK

U2 - 10.1016/S1556-0864(16)30265-9

DO - 10.1016/S1556-0864(16)30265-9

M3 - Article

AN - SCOPUS:85029246459

SN - 1556-0864

VL - 11

SP - S125

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4

ER -

155P: PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel–cisplatin chemotherapy

UN SDGs

Access to Document

Other files and links

Cite this